Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
Holding ARTV?
Track your performance easily

Artiva Biotherapeutics, Inc. (ARTV) Similar Stocks

8 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Adaptimmune Therapeutics
$243.02M
-2.75
21.79%
5 Buy
2 Hold
1 Sell
Moderate Buy
Allogene Therapeutics
$585.51M
-1.74
-11.67%
9 Buy
2 Hold
0 Sell
Strong Buy
Fate Therapeutics
$398.57M
-2.05
65.09%
3 Buy
9 Hold
0 Sell
Hold
Karyopharm Therapeutics
$103.49M
-0.70
-38.06%
4 Buy
1 Hold
0 Sell
Strong Buy
Artiva Biotherapeutics, Inc.
$375.24M
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ADAP
Adaptimmune Therapeutics
0.95
0.20
26.67%
ALLO
Allogene Therapeutics
2.80
-0.30
-9.68%
FATE
Fate Therapeutics
3.50
1.58
82.29%
KPTI
Karyopharm Therapeutics
0.83
-0.39
-31.97%
ARTV
Artiva Biotherapeutics, Inc.
15.45
3.68
31.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis